Using data from the WHO ISARIC CCP-UK cohort, Dr. Lance Turtle and colleagues report on the outcome of COVID-19 in immunocompromised patients that are hospitalised.
Although seroprevalence is declining, a significant proportion of Europe s population
is infected with HSV-2. HSV-2 accounts for approximately one-fifth of GUD cases and
two-thirds of genital herpes cases. Findings support the need to invest in HSV-2 vaccine
development, and sexual and reproductive health services.
I have a research and clinical background, with a PhD in Health Sciences and experience in working as an NHS nurse, which has developed my interest and expertise in researching inequalities in healthcare access. I work in the NIHR Health Protection Research Unit (HPRU) in Immunisation, jointly run by Public Health England (PHE) and LSHTM.
Former vaccine tsar Kate Bingham, pictured, was accused the civil service of taking their foot off the gas in the search for new and more effective Covid-19 vaccinations.